Braskem (BAK) Cash & Equivalents (2009 - 2025)

Braskem's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.9 billion for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 24.47% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (down 24.47% YoY), while the FY2025 annual figure was $1.9 billion, down 24.47% from the prior year.
• Cash & Equivalents was $1.9 billion for Q4 2025 at Braskem, up from $1.9 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.9 billion in Q4 2023 to a low of $1.6 billion in Q4 2021.
• Historically, Cash & Equivalents has averaged $2.4 billion across 5 years, with a median of $2.5 billion in 2023.
• Biggest YoY gain for Cash & Equivalents was 109.82% in 2021; the steepest drop was 39.39% in 2021.
• A 5-year view of Cash & Equivalents shows it stood at $1.6 billion in 2021, then soared by 52.26% to $2.4 billion in 2022, then advanced by 20.94% to $2.9 billion in 2023, then retreated by 10.02% to $2.6 billion in 2024, then decreased by 24.47% to $1.9 billion in 2025.
• The last three Cash & Equivalents figures came in at $1.9 billion (Q4 2025), $1.9 billion (Q1 2025), and $2.6 billion (Q4 2024), per Business Quant data.